Exhibit 99.2
Ayr Wellness Inc.
(Formerly Ayr Strategies Inc.)
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020
(EXPRESSED IN UNITED STATES DOLLARS)
Ayr Wellness Inc.
(Formerly Ayr Strategies Inc.)
CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2021 AND 2020
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Ayr Wellness Inc. (formerly Ayr Strategies Inc.) (the “Company”) as of December 31, 2021 and 2020, the related consolidated statements of operations, shareholders’ equity and cash flows for each of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Marcum LLP
We have served as the Company’s auditor since 2021.
March 17, 2022
1
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Consolidated Balance Sheets
(Expressed in United States Dollars, Except Number of Shares)
Year Ended | ||||||
| December 31, 2021 |
| December 31, 2020 | |||
ASSETS |
|
| ||||
Current |
|
|
|
| ||
Cash | $ | | $ | | ||
Accounts receivable, net |
| |
| | ||
Due from related parties |
| – |
| | ||
Inventory, net |
| |
| | ||
Prepaid expenses, deposits, & other current assets |
| |
| | ||
$ | | $ | | |||
Non-current |
|
|
|
| ||
Property, plant, & equipment, net |
| |
| | ||
Intangible assets, net |
| |
| | ||
Right-of-use assets - operating |
| |
| | ||
Right-of-use assets - finance, net | | | ||||
Goodwill |
| |
| | ||
Equity investments |
| – |
| | ||
Deposits & other assets |
| |
| | ||
Total assets | $ | | $ | | ||
LIABILITIES & SHAREHOLDERS' EQUITY |
|
|
|
| ||
Liabilities | ||||||
Current |
|
|
|
| ||
Trade payables | $ | | $ | | ||
Accrued liabilities |
| |
| | ||
Lease liabilities - operating - current portion |
| |
| | ||
Lease liabilities - finance - current portion | | | ||||
Contingent consideration - current portion | | | ||||
Purchase consideration payable |
| |
| | ||
Income tax payable |
| |
| | ||
Debts payable - current portion |
| |
| | ||
Accrued interest payable - current portion | | | ||||
$ | | $ | | |||
Non-current |
|
| ||||
Deferred tax liabilities | | | ||||
Lease liabilities - operating - non-current portion |
| |
| | ||
Lease liabilities - finance - non-current portion |
| |
| | ||
Contingent consideration - non-current portion |
| |
| | ||
Debts payable - non-current portion |
| |
| | ||
Senior secured notes, net of debt issuance costs - non-current portion |
| |
| | ||
Accrued interest payable - non-current portion |
| |
| | ||
Total liabilities | $ | | $ | | ||
Commitments and contingencies | ||||||
Shareholders' equity |
|
|
|
| ||
Multiple Voting Shares: |
|
| ||||
Subordinate, Restricted, & Limited Voting Shares: |
|
| ||||
Exchangeable Shares: |
|
| | |||
Additional paid-in capital | | | ||||
Treasury stock - | ( | ( | ||||
Accumulated other comprehensive income |
| |
| | ||
Deficit |
| ( |
| ( | ||
Total shareholders' equity | $ | | $ | | ||
Total liabilities & shareholders' equity | $ | | $ | |
The accompanying notes are an integral part of these consolidated financial statements.
2
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Consolidated Statements of Operations
(Expressed in United States Dollars, Except Number of Shares)
Year Ended | ||||||
| December 31, 2021 |
| December 31, 2020 | |||
Revenues, net of discounts | $ | |
| $ | | |
Cost of goods sold excluding fair value items |
| |
| | ||
Incremental costs to acquire cannabis inventory in a business combination |
| |
| – | ||
Cost of goods sold | $ | | $ | | ||
Gross profit | $ | | $ | | ||
Operating expenses |
|
|
|
| ||
General and administrative |
| |
| | ||
Sales and marketing |
| |
| | ||
Depreciation and amortization |
| |
| | ||
Amortization on intangible assets |
| |
| | ||
Acquisition expense |
| |
| | ||
Total operating expenses | $ | | $ | | ||
(Loss) income from operations | $ | ( | $ | | ||
Other income (expense) |
|
|
|
| ||
Share of loss on equity investments |
| ( |
| ( | ||
Foreign exchange |
| ( |
| ( | ||
Fair value gain (loss) on financial liabilities |
| |
| ( | ||
Interest expense, net |
| ( |
| ( | ||
Interest income |
| |
| | ||
Other, net |
| |
| | ||
Total other income (expense) | $ | | $ | ( | ||
Income (Loss) before taxes | $ | | $ | ( | ||
Income Taxes | ||||||
Current tax provision |
| ( |
| ( | ||
Deferred tax benefit (provision) |
| |
| ( | ||
Total income taxes | $ | ( | $ | ( | ||
Net loss | $ | ( | $ | ( | ||
Basic and diluted loss per share | ( | ( | ||||
Weighted average number of shares outstanding (basic and diluted) |
| |
| |
The accompanying notes are an integral part of these consolidated financial statements.
3
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Consolidated Statements of Shareholders’ Equity
(Expressed in United States Dollars, Except Number of Shares)
Subordinate, | Accumulated other | |||||||||||||||||
Multiple | Restricted, and Limited | Exchangeable | Additional paid- | Treasury Stock | comprehensive |
| ||||||||||||
| Voting Shares | Voting Shares |
| Shares |
| in capital | Number |
| Amount | income | Deficit | Total | ||||||
| # |
| # |
| # |
| $ |
| # |
| $ |
| $ |
| $ |
| $ | |
Balance, December 31, 2019 |
| |
| |
| |
| | ( |
| ( |
| |
| ( |
| | |
Stock-based compensation |
| – |
| – |
| – |
| | – |
| – |
| – |
| – |
| | |
Exercise of Rights |
| – |
| |
| – |
| – | – |
| – |
| – |
| – |
| – | |
Exercise of Warrants |
| – |
| |
| – |
| | – |
| – |
| – |
| – |
| | |
Conversion of Exchangeable Shares |
| – |
| |
| ( |
| – | – |
| – |
| – |
| – |
| – | |
Share issuance - make-whole |
| – |
| – |
| |
| | – |
| – |
| – |
| – |
| | |
Share issuance - business combination and asset acquisition |
| – |
| |
| |
| | – |
| – |
| – |
| – |
| | |
Repurchase of Subordinate Voting Shares |
| – |
| – |
| – |
| – | ( |
| ( |
| – |
| – |
| ( | |
Net loss |
| – |
| – |
| – |
| – | – |
| – |
| – |
| ( |
| ( | |
Balance, December 31, 2020 |
| |
| |
| |
| | ( |
| ( |
| |
| ( |
| | |
Subordinate, | Accumulated other | |||||||||||||||||
Multiple | Restricted, and Limited | Exchangeable | Additional paid- | Treasury Stock | comprehensive |
| ||||||||||||
| Voting Shares | Voting Shares |
| Shares |
| in capital | Number |
| Amount | income | Deficit | Total | ||||||
| # |
| # |
| # |
| $ |
| # |
| $ |
| $ |
| $ |
| $ | |
Balance, December 31, 2020 |
| |
| |
| |
| | ( | ( | |
| ( |
| | |||
Stock-based compensation |
| – |
| |
| – |
| | – |
| – |
| – |
| – |
| | |
Tax withholding on stock-based compensation awards |
| – |
| ( | – |
| ( | – |
| – |
| – |
| – |
| ( | ||
Exercise of Rights |
| – |
| |
| – |
| – | – |
| – |
| – |
| – |
| – | |
Exercise of Warrants |
| – |
| |
| – |
| | – |
| – |
| – |
| – |
| | |
Conversion of Exchangeable Shares |
| – |
| |
| ( |
| – | – |
| – |
| – |
| – |
| – | |
Share issuance - business combinations, asset acquisition, and equity investment |
| – |
| |
| |
| | – |
| – |
| – |
| – |
| | |
Replacement options issued - business combinations |
| – |
| – |
| – |
| | – |
| – |
| – |
| – |
| | |
Equity offering |
| – |
| |
| – |
| | – |
| – |
| – |
| – |
| | |
Exercise of options, net of options sold to cover income taxes | – | |
| – | | – |
| – |
| – | – | | ||||||
Conversion of convertible debt | – | |
| – | | – | – |
| – | – | | |||||||
Repurchase of Subordinate Shares |
| – |
| ( | – |
| ( | ( |
| ( | – |
| – |
| ( | |||
Net loss |
| – |
| – |
| – |
| – | – |
| – |
| – |
| ( |
| ( | |
Balance, December 31, 2021 |
| |
| |
| |
| | ( |
| ( |
| |
| ( |
| |
The accompanying notes are an integral part of these consolidated financial statements
4
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Consolidated Statements of Cash Flows
(Expressed in United States Dollars)
Year Ended | ||||||
December 31, | December 31, | |||||
| 2021 |
| 2020 | |||
Operating activities |
|
| ||||
Net loss | $ | ( | $ | ( | ||
Adjustments for: |
|
|
|
| ||
Net fair value (gain) loss on financial liabilities |
| ( |
| | ||
Stock-based compensation |
| |
| | ||
Depreciation and amortization |
| |
| | ||
Amortization on intangible assets |
| |
| | ||
Share of loss on equity investments |
| |
| | ||
Gain on disposal of equity investments | ( | – | ||||
Incremental costs to acquire cannabis inventory in a business combination |
| |
| – | ||
Loss on disposal of property, plant, and equipment | | – | ||||
Deferred tax (benefit) expense |
| ( |
| | ||
Amortization on financing costs |
| |
| | ||
Amortization on financing premium | ( | – | ||||
Changes in operating assets and liabilities, net of business acquisition: |
|
|
| |||
Accounts receivable |
| ( |
| ( | ||
Inventory |
| ( |
| ( | ||
Prepaid expenses and other current assets |
| ( |
| ( | ||
Trade payables |
| ( |
| | ||
Accrued liabilities |
| |
| | ||
Interest accrued | | | ||||
Lease liabilities - operating | | | ||||
Income tax payable |
| |
| | ||
Cash (used in) provided by operating activities |
| ( |
| | ||
Investing activities |
|
|
|
| ||
Purchase of property, plant, and equipment |
| ( |
| ( | ||
Purchases of intangible assets |
| – |
| ( | ||
Cash paid for business combinations and asset acquisitions, net of cash acquired |
| ( |
| ( | ||
Cash paid for business combinations and asset acquisitions, bridge financing |
| ( |
| ( | ||
Cash paid for business combinations and asset acquisitions, working capital |
| ( |
| ( | ||
Payments for interests in equity accounted investments |
| ( |
| ( | ||
Cash received in disposal of equity investment | | – | ||||
Payments made by (advances to) related corporation |
| |
| ( | ||
Cash paid for bridge financing | ( | – | ||||
Deposits for business combinations |
| ( |
| ( | ||
Cash used in investing activities |
| ( |
| ( | ||
Financing activities |
|
|
|
| ||
Proceeds from exercise of Warrants |
| |
| | ||
Proceeds from exercise of options | | – | ||||
Proceeds from equity offering, net of expenses | | – | ||||
Proceeds from senior secured notes, net of financing costs | | | ||||
Payments of financing costs | ( | – | ||||
Tax withholding on stock-based compensation awards | ( | – | ||||
Repayments of debts payable |
| ( |
| ( | ||
Repayments of lease liabilities - finance (principal portion) |
| ( |
| ( | ||
Repurchase of Subordinate Shares |
| ( |
| ( | ||
Cash provided by financing activities |
| |
| | ||
Net increase in cash |
| |
| | ||
Cash, beginning of the period |
| |
| | ||
Cash, end of the period |
| |
| | ||
Supplemental disclosure of cash flow information: |
|
|
|
| ||
Interest paid during the period |
| |
| | ||
Income taxes paid during the period |
| |
| | ||
Non-cash investing and financing activities: | ||||||
Recognition of right-of-use assets for operating leases | | | ||||
Recognition of right-of-use assets for finance leases | | | ||||
Issuance of Subordinate Shares related to business combinations, asset acquisitions, and make-whole provision | | | ||||
Issuance of Subordinate Shares related to equity component of debt | | – | ||||
Repurchase of Subordinate Shares | | – |
The accompanying notes are an integral part of these consolidated financial statements.
5
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
1. NATURE OF OPERATIONS
Ayr Wellness Inc. (formerly Ayr Strategies Inc.) (“Ayr” or the “Company”) is a vertically integrated cannabis multi-state operator in the U.S., with cannabis operations in Massachusetts, Nevada, Pennsylvania, Florida, Arizona, New Jersey, and Ohio as of December 31, 2021. Through its operating companies, Ayr is a leading cultivator, manufacturer, and retailer of cannabis products and branded cannabis packaged goods. The Company prepares its segment reporting on the same basis that its chief operating decision maker manages the business and makes operating decisions. The Company has
The Company is a reporting issuer in the United States and Canada. The Company’s subordinate, restricted, and limited voting shares (“Subordinate Shares”) are trading on the Canadian Stock Exchange (the “CSE”), under the symbol “AYR.A”. The Company’s Subordinate Shares are also trading on the Over-the-Counter Market (“OTC”) in the United States under the symbol “AYRWF”. The Company originally traded on the OTC under the symbol “AYRSF”, however, that changed on December 4, 2020 to “AYRWF”. The Company’s warrants (“Warrants”) and rights (“Rights”) were trading on the CSE under the symbols “AYR.WT” and “AYR.RT”, however, they stopped trading on September 30, 2021 and May 24, 2021, respectively.
History of the Company
The Company was incorporated on July 31, 2017 under the Business Corporations Act (Ontario) and continued on May 24, 2019 into British Columbia under the Business Corporations Act (British Columbia) in connection with its Qualifying Transaction, as defined below. The registered office of the Company is located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8. The head office of the Company is located at 2601 South Bayshore Drive, Suite 900, Miami, FL, 33133.
On September 12, 2018, the Company incorporated a wholly-owned subsidiary in Nevada, United States, named CSAC Holdings Inc., to facilitate the proposed Qualifying Transaction. On September 17, 2018, CSAC Holdings Inc. incorporated a wholly-owned subsidiary in Nevada, United States, named CSAC Acquisition Inc. (“CSAC AcquisitionCo”).
On May 24, 2019, the Company acquired Washoe Wellness, LLC (“Washoe”), The Canopy NV, LLC (“Canopy”), Sira Naturals, Inc. (“Sira”), LivFree Wellness, LLC (“LivFree”) and CannaPunch of Nevada LLC (“CannaPunch”), which collectively constituted its Qualifying Transaction (collectively, the “Qualifying Transaction”). The Company was deemed the accounting acquirer in control of the business of the Qualifying Transaction.
2. BASIS OF PRESENTATION
2.1 Statement of compliance
On March 1, 2021, the United States Securities and Exchange Commission (“SEC”) declared effective the Company’s Registration Statement (No. 333-253466) on Form F-10 (“the Registration Statement”) filed on February 24, 2021. The Registration Statement was made by a foreign issuer that is permitted, under the U.S. / Canada Multijurisdictional Disclosure System (“MJDS”) adopted by the United States, to prepare the Registration Statement in accordance with the disclosure requirements of Canadian issuers. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and in accordance with the rules and regulations of Canadian securities regulators and the SEC.
The financial statements are presented in United States dollars (“US$” or “$”) which, following the close of the Qualifying Transaction, became the Company’s presentation currency. The functional currency of each entity is determined separately in accordance with Accounting Standards Codification (ASC) 830 – Foreign Currency Matters and is measured using the currency of the primary economic environment in which the entity operates (“the functional currency”). The functional currency of Ayr is US$.
6
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3.1 Basis of consolidation
The financial statements for the years ended December 31, 2021 and 2020 include the accounts of the Company, its wholly-owned subsidiaries, and entities over which the Company has a controlling interest. Entities over which the Company has control are presented on a consolidated basis from the date control commences until the date control ceases. Equity investments where the Company does not exert a controlling interest are not consolidated. All intercompany balances and transactions involving controlled entities are eliminated on consolidation. The Company’s consolidated subsidiaries, many of which were created in connection with the business combinations described in Note 4 and elsewhere in these financial statements, are listed below, and are owned 100% by the Company unless otherwise noted:
Subsidiaries |
| State of operation |
| Purpose |
|
Ayr Wellness Inc. | British Columbia, CA | Parent Company | |||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
NV | Corporate - Holding Company | ||||
OH | Corporate - Holding Company | ||||
NV | Management Company | ||||
NV | Production | ||||
MA | Cultivation, Production, and Retail | ||||
NV | Branded Manufactured Products | ||||
NV | Retail | ||||
NV | Cultivation | ||||
NV | Production | ||||
NV | Retail | ||||
NV | Retail | ||||
PA | Cultivation and Production | ||||
PA | Cultivation, Production, and Retail | ||||
AZ | Corporate - Holding Company | ||||
AZ | Cultivation, Production, and Retail | ||||
AZ | Cultivation, Production, and Retail | ||||
AZ | Cultivation | ||||
FL | Real Estate | ||||
FL | Cultivation, Production, and Retail | ||||
OH | Managed Services - Cultivation | ||||
OH | Real Estate | ||||
NJ | Cultivation, Production, and Retail | ||||
PA | Retail | ||||
MA | Retail | ||||
NV | Real Estate | ||||
NV | Real Estate | ||||
NV | Real Estate | ||||
AZ | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
FL | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
NV | Payroll | ||||
NV | Corporate |
7
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.2 Revenue
Accounting Standards Update (“ASU”) 2014-09 – Revenue from Contracts with Customers (“ASC 606”), which was codified in Accounting Standards Codification “ASC” Topic 606, specifies how and when revenue should be recognized based on a five-step model, which is applied to all contracts with customers. Through the application of the standard, the Company applies the following five-step model to determine the amount and timing of revenue to be recognized:
● | Identifying the contract with a customer |
● | Identifying the performance obligations within the contract |
● | Determining the transaction price |
● | Allocating the transaction price to the performance obligations |
● | Recognizing revenue when/as performance obligation(s) are satisfied. |
In some cases, judgment is required in determining whether the customer is a business or the end consumer. This evaluation is made based on whether the business obtains control of the product before transferring to the end consumer. Control of the product transfers at a point in time either upon shipment to or receipt by the customer, depending on the contractual terms. In determining the appropriate time of sale, the Company takes into consideration a) the Company’s right to payment for the goods or services; b) customer’s legal title; c) transfer of physical possession of the goods; and d) timing of acceptance of goods.
Revenue is recognized based on the sale of cannabis products and branded packaged goods for a fixed price when control is transferred. The amount recognized reflects the consideration that the Company expects to receive, taking into account any variation that is expected to result from rights of return and discounts. Dispensary revenue is recognized at the point of sale while wholesale revenue is recognized once Ayr transfers the significant risks and rewards of ownership of the goods and does not retain material involvement associated with ownership or control over the goods sold. In accordance with ASC 606, the Company has elected to account for its sales and excise tax on a net basis, within its Statements of Operations.
3.3 Cash and cash equivalents
The Company considers the following to be cash and cash equivalents: cash deposits in financial institutions, cash held in Company safes or lockboxes at operational locations, and deposits that are readily convertible into cash within three months or less. The Company has banking or similar relationships in all jurisdictions in which it operates. In addition, the Company has cash balances in excess of Federal Deposit Insurance Corporation (the “FDIC”) and Canadian Deposit Insurance Corporation (the “CDIC”) limits. As of December 31, 2021 and 2020, there are
3.4 Accounts receivable
Accounts receivable from wholesale sales are recorded net of an allowance for doubtful accounts. The Company estimates allowance for doubtful accounts based on various factors such as historical data and specific customer situations. As of December 31, 2021, and 2020, the Company had approximately $
8
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.5 Business combinations
Acquisitions of subsidiaries and businesses are accounted for using the acquisition method in accordance with ASC 805 – Business Combination (“ASC 805”). The Company performs an assessment whether the acquisition is a business combination or asset acquisition based on the conditions surrounding the event using guidance from ASC 805. If the acquisition is determined to be a business combination, the Company measures goodwill as the fair value of the consideration transferred, including the recognized amount of any non-controlling interest in the acquiree, less the net recognized amount of the identifiable assets acquired and liabilities assumed, all measured as of the acquisition date.
Consideration transferred includes the fair value of the assets transferred (including cash), the liabilities incurred by the Company on behalf of the acquiree, any contingent consideration and any equity interests issued by the Company. Transaction costs, other than those directly associated with the issuance of debt or equity securities that the Company incurs in connection with a business combination, are expensed as incurred.
The acquisition date is the date when the Company obtains control of the acquiree. Contingent consideration is measured at its acquisition date fair value and included as part of the consideration transferred in a business combination. Contingent consideration that is classified as a liability is re-measured at subsequent reporting dates in accordance with the criteria and guidance provided under ASC 450 – Contingencies and ASC 820 – Fair Value Measurement, as appropriate with corresponding gain or loss recorded in the statements of operations, see Note 13.
3.6 Inventory
Inventories are primarily comprised of finished goods, work-in-process, raw materials, and supplies. Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Raw materials and work-in-process are stated at the lower of cost and net realizable value, with cost being determined using the weighted average cost method. Finished goods inventory is stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out (“FIFO”) accounting method.
Costs incurred during the growing process are capitalized as incurred to the extent that cost is less than net realizable value. Any subsequent post-harvest costs, including direct costs such as materials, labor, related overhead, and depreciation expense on equipment attributable to processing, are capitalized to inventory to the extent that cost is less than net realizable value. Inventories of purchased finished goods and packing materials, other than inventory acquired through business combinations, are initially valued at cost and subsequently at the lower of cost and net realizable value. The Company reviews inventories for obsolete, spoiled, and slow-moving goods and any such inventories identified are written down to net realizable value. Inventory acquired in a business combination is valued at fair value less selling costs.
3.7 Property, plant, and equipment (“PPE”)
PPE is stated at cost less accumulated depreciation, amortization, and impairment losses, if any. The cost of an item of PPE consists of the purchase price, any costs directly attributable to bringing the asset to the location and condition necessary for its intended use and an initial estimate of the costs of dismantling and removing the item and restoring the site on which it is located. PPE acquired in a business combination is initially recorded at fair value.
9
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.7 Property, plant, and equipment (“PPE”) (continued)
Depreciation and amortization are provided at rates calculated to write off the cost of PPE, less their estimated residual value, using the straight-line method over the following expected useful lives:
● | Furniture and fixtures – |
● | Office equipment – |
● | Machinery and equipment – |
● | Auto and trucks – |
● | Leasehold improvements – the shorter of the useful life or life of the lease |
● | Buildings – |
● | Land – not depreciated |
● | Construction in progress – not depreciated until placed in service |
An item of PPE is derecognized upon disposal, when held for sale, or when no future economic benefits are expected to arise from the continued use of the asset. Any gain or loss arising on disposal of the asset, determined as the difference between the net disposal proceeds and the carrying amount of the asset, is recognized in the statements of operations.
Construction in progress is transferred to the appropriate asset class when available for use and depreciation or amortization of the assets commences at that point of time.
The Company conducts a periodic assessment of the residual balances, useful lives, and depreciation or amortization methods being used for PPE and any changes arising from the assessment are applied by the Company prospectively.
Where an item of PPE comprises major components with different useful lives, the components are accounted for as separate items of PPE. Expenditures incurred to replace a component of an item of PPE that is accounted for separately, including major inspection and overhaul expenditures are capitalized.
The Company capitalizes interest on debt in projects under construction. Upon the asset becoming available for use, capitalized interest costs, as a portion of the total cost of the asset, are depreciated over the estimated useful life of the related asset.
3.8 Intangible assets
Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets, separately identifiable according to ASC 805 – Business Combinations, acquired in a business combination are initially measured at fair value as of the acquisition date. Amortization periods of assets with finite lives are based on management’s estimates at the date of acquisition and are amortized over their estimated useful lives. Intangible assets that have indefinite useful lives are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
10
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.8 Intangible assets (continued)
(a) | Goodwill |
The Company measures goodwill as the fair value of the consideration transferred, including the recognized amount of any non-controlling interest in the acquiree, less the net recognized amount of the identifiable assets and liabilities assumed, all measured as of the acquisition date. Goodwill is allocated to a specific reporting unit upon acquisition. The Company’s policy is to first perform a qualitative assessment to determine if it was more-likely-than-not that the reporting unit’s carrying value is less than the fair value, indicating the potential for goodwill impairment. The amount of goodwill impairment, if any, is determined as the excess of the carrying value of the reporting unit’s goodwill over the fair value of that reporting unit. Impairment testing is performed annually by the Company, or more frequently, if events or changes in circumstances indicate that goodwill might be impaired. Management makes estimates during impairment testing as judgment is required to determine indicators of impairment and estimates are used to determine the fair value that is used to measure impairment losses. The Company assesses the fair values of its intangible assets, and its reporting unit for goodwill testing purposes, as necessary, using an income-based approach. Under the income approach, fair value is based on the present value of estimated future cash flows.
(b) | Finite-lived intangible assets |
Intangible assets are recorded at cost unless acquired through a business combination and recorded at fair value, less accumulated amortization and impairment losses. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. Intangible assets, which include licences/permits, right-to-use licenses, host community agreements, and trade name/brand have useful lives of
(c) | Impairment of long-lived assets |
Long-lived assets such as PPE and finite-lived intangible assets are grouped with other assets and liabilities at the lowest level for which identifiable independent cash flows are available (“asset group”). The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, the impairment test is a two-step approach wherein the recoverability test is performed first to determine whether the long-lived asset is recoverable. The recoverability test (Step 1) compares the carrying amount of the asset to the sum of its future undiscounted cash flows using entity specific assumptions generated through the asset’s use and eventual disposition. If the carrying amount of the asset is less than the cash flows, the asset is recoverable and an impairment is not recorded. If the carrying amount of the asset is greater than the cash flows, the asset is
3.9 Leases
The Company applies the accounting guidance in ASC 842 – Leases, and assesses whether a contract is or contains a lease, at inception of a contract. Leases are recognized as a right-of-use asset (“ROU”) and corresponding liability at the commencement date based on the present value of the future minimum lease payments over the lease term. Operating leases are included in ROU – operating and lease liabilities – operating on the balance sheets. For operating leases, the Company records operating lease expense. Finance leases are included in ROU – finance, net and lease liabilities – finance are included in other current liabilities and other non-current liabilities on the balance sheets based on their payment dates. For finance leases, the Company records interest expense on the lease liability in addition to amortizing the right-of-use asset (generally straight-line) over the shorter of the lease term or the useful life of the right-of-use asset. The Company primarily leases space for corporate offices, retail, cultivation, and manufacturing under non-cancellable operating leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease.
11
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.9 Leases (continued)
Lease liabilities include the net present value of fixed payments (including in-substance fixed payments), variable lease payments that are not based on an index or a rate or subject to a fair market value renewal, amounts expected to be payable by the lessee under residual value guarantees, the exercise price of a purchase option if the lessee is reasonably certain to exercise that option, and payments of penalties for terminating the lease, if the lease term reflects the lessee exercising that option. The Company allocates the consideration in the contract to each lease component on the basis of the relative standalone price of the lease component and the aggregate stand-alone price of the non-lease components. The lease payments are discounted using the interest rate implicit in the lease or, if that rate cannot be determined, the Company’s incremental borrowing rate. The period over which the lease payments are discounted is the reasonably certain lease term, including renewal options that the Company is reasonably certain to exercise. Renewal options are included in a number of leases across the Company.
Payments associated with short-term leases are recognized as an expense on a straight-line basis in the statements of operations. Short-term leases are leases with a lease term of 12 months or less. Variable lease payments that depend on an index or a rate or are subject to a fair market value renewal are expensed as incurred and recognized in the statements of operations.
3.10 Equity investments
An associate is an entity over which the Company exercises significant influence. Significant influence is the power to participate in the financial and operating policy of the investee but without control or joint control over those policies. Interests in associates are accounted for using the equity method and are initially recognized at cost. Subsequent to initial recognition, the carrying value of the Company’s interest in an associate is adjusted for the Company’s share of income or loss and distributions of the investee. The carrying value of associates is assessed for impairment at each balance sheet date. Significant influence is presumed if the Company holds between
Joint control is the contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities require the unanimous consent of the parties sharing control. Investees in which the Company has joint control and rights to the net assets thereof are defined as joint ventures. Joint ventures are also accounted for under the equity method.
3.11 Non-controlling interests
Equity interests owned by parties that are not shareholders of the Company in consolidated subsidiaries are considered non-controlling interests. The share of net assets attributable to non-controlling interests are presented as a component of equity while the share of net income or loss is recognized in the statements of operations. Changes in Ayr’s ownership interest that do
3.12 Derivatives
The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting date, with changes in the fair value reported in the Company’s financial statements. In calculating the fair value of derivative liabilities, the Company uses a valuation model when Level 1 inputs are not available to estimate fair value at each reporting date (see Note 16).
The classification of derivative instruments, including whether such instruments should be recognized as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the financial statement date.
12
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.13 Loss per share
The basic loss per share is computed by dividing the net loss by the weighted average number of shares outstanding, including Subordinate Shares, multiple voting shares of the Company (“Multiple Voting Shares”), and Exchangeable Shares (as defined in Note 4), during the period. The diluted loss per share reflects the potential dilution of shares by adjusting the weighted average number of shares outstanding to assume conversion of potentially dilutive shares, such as Warrants, restricted stock units (“RSUs”), and vested options. The “treasury stock method” is used for the assumed proceeds upon the exercise of the Exchangeable Shares, Warrants, and vested options that are used to purchase Subordinate Shares at the average market price during the period. If the Company incurs a net loss during a reporting period, the calculation of fully diluted loss per share will not include potentially dilutive equity instruments such as Warrants, RSUs, contingent shares, and vested options, therefore, basic loss per share and diluted loss per share will be the same.
Year Ended | ||||
Potential Diluted Shares Breakout |
| December 31, 2021 |
| December 31, 2020 |
Warrants |
| |
| |
Rights |
| – |
| |
Options |
| |
| – |
RSUs |
| |
| |
Total |
| |
| |
3.14 Stock-based payments
(a) Stock-based payment transactions
Certain employees (including directors and senior executives) of the Company receive a portion of their remuneration in the form of stock-based payment transactions, whereby employees render services as consideration for equity instruments.
Stock-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued. In situations where equity instruments are issued to non-employees and some or all of the fair value of the good or service received by the Company as consideration cannot be specifically identified, they are measured at fair value of the stock-based payment. Stock-based payment transactions are primarily for individuals whose compensation has been classified as part of general and administrative expenses in the statement of operations.
The costs of equity-settled transactions with employees are measured by reference to the fair value of the stock price at the date on which they are granted, using an appropriate valuation model. The value of the transaction is expensed through the vesting period. Market and performance based RSUs are fair valued through Monte-Carlo simulations and are expensed over the indicative service period. Performance RSUs are recorded once the condition is probable to occur.
The costs of equity-settled transactions are recognized, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (the “vesting date”).
The cumulative expense is recognized for equity-settled transactions at each reporting date until the vesting date as the Company’s policy is to account for forfeitures as they occur. The income or loss for a period represents the movement in cumulative expense recognized as of the beginning and end of that period and the corresponding amount is represented in additional paid-in capital. At the end of each reporting period, the Company assesses if any forfeitures occurred and recognizes the impact in the statements of operations.
No expense is recognized for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition, which are treated as vesting for expense purposes irrespective of whether or not the market condition is satisfied provided that all other performance and/or service conditions are satisfied.
13
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.14 Stock-based payments (continued)
(a) Stock-based payment transactions (continued)
Where the terms of an equity settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided the original terms of the award are met. An additional expense is recognized for any modification which increases the total fair value of the stock-based payment arrangement or is otherwise beneficial to the employee as measured at the date of modification. When an award is cancelled by the Company or the counterparty, any remaining element of the fair value of the award is derecognized at that time through the statements of operations.
RSUs are issued on the vesting dates, sometimes net of the applicable statutory tax withholding to be paid by the Company on behalf of the employees. In those instances, lower shares are issued than the number of RSUs vested and the tax withholding is recorded as a reduction to paid-in capital. The terms of the stock-based payment awards allow an entity with a statutory income tax withholding obligation to withhold shares with a fair value up to the maximum statutory tax in the employee’s applicable jurisdiction.
(b) Warrants
The Company determines the accounting classification of warrants, as either liability or equity, by assessing ASC 480 – Distinguishing Liabilities from Equity and ASC 815 – Derivatives and Hedging. Under ASC 480, warrants are considered a liability if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing a variable number of shares. Under ASC 815, warrants are considered liabilities if contracts require or may require the issuer to net settle the contract for cash. Such derivatives are recorded as a liability at fair value until they are settled or expire, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature.
After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date unless the warrants are modified.
The Company determined that all of its outstanding warrants are freestanding instruments which do not meet the characteristics of a liability and therefore are classified as equity.
3.15 Loss contingencies
Loss contingencies are recognized when the Company has a present obligation that has arisen as a result of a past event and it is probable that a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount of the obligation. Loss contingencies are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the time value of money and the risk specific to the obligation.
3.16 Financial instruments
Recognition and initial measurement
Financial assets and financial liabilities, including derivatives, are recognized when the Company becomes a party to the contractual provisions of a financial instrument or non-financial derivative contract. All financial instruments are measured at fair value on initial recognition. Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities, other than financial assets and financial liabilities classified as FVTPL (as defined below), are added to or deducted from the fair value on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified as FVTPL are recognized immediately in the statements of operations.
14
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.16 Financial instruments (continued)
Classification and subsequent measurement
The Company classifies financial assets, at the time of initial recognition, according to the Company’s business model for managing the financial assets and the contractual terms of the cash flows. Financial assets are classified in the following measurement categories:
a) | amortized cost (“AC”); |
b) | fair value through profit or loss (“FVTPL”); and |
c) | fair value through other comprehensive income (“FVTOCI”). |
Financial assets are subsequently measured at amortized cost if both of the following conditions are met and they are not designated as FVTPL: a) the financial asset is held within a business model whose objective is to hold financial assets to collect contractual cash flows; and b) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
These assets are subsequently measured at amortized cost using the effective interest rate method, less any impairment, with gains and losses recognized in the statements of operations in the period that the asset is derecognized or impaired. All financial assets not classified at amortized cost as described above are measured at FVTPL or FVTOCI depending on the business model and cash flow characteristics. The Company has no financial assets measured at FVTOCI.
Financial liabilities are subsequently measured at amortized cost using the effective interest rate method with gains and losses recognized in the statements of operations in the period that the liability is derecognized, except for financial liabilities classified as FVTPL.
Refer to Note 16 for the classification and fair value (“FV”) level of financial instruments.
Derecognition
The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition are recognized in the statements of operations.
The Company derecognizes financial liabilities only when its obligations under the financial liabilities are discharged, cancelled, or expired. Generally, the difference between the carrying amount of the financial liability derecognized and the consideration paid and payable, including any non-cash assets transferred or liabilities assumed, is recognized in the statements of operations.
3.17 Foreign currency transactions and translations
Foreign currency transactions are translated into the functional currency of the entity using the exchange rates prevailing at the dates of the transactions or valuation where items are re-measured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies, such as remeasurement of local currency into functional currency, are recognized in the statements of operations.
The results and financial position of an entity that has a functional currency different from the presentation currency is translated into the presentation currency as follows:
● | assets and liabilities for each balance sheet presented are translated at the closing rate at the date of the balance sheet; and |
● | income and expenses for each statement of operations are translated at average exchange rates (unless this average is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated as the rate on the dates of the transactions). |
15
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.17 Foreign currency transactions and translations (continued)
Effect of translation differences, such as translation of foreign currency into reporting currency, are accumulated and presented as a component of equity under accumulated other comprehensive income.
3.18 Taxation
The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. Ayr recognizes deferred tax assets to the extent that Ayr believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If Ayr determines that Ayr would be able to realize our deferred tax assets in the future in excess of their net recorded amount, Ayr would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional tax expense based upon the outcomes of such matters. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were
As the Company operates in the cannabis industry, the Company is subject to the limits of the United States Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production.
16
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.19 Significant accounting judgments and estimates
The application of the Company’s accounting policies requires management to use estimates and judgments that can have a significant effect on the revenues, expenses, assets and liabilities recognized, and disclosures made in the financial statements.
Management’s best estimates concerning the future are based on the facts and circumstances available at the time estimates are made. Management uses historical experience, general economic conditions, and assumptions regarding probable future outcomes as the basis for determining estimates. Estimates and their underlying assumptions are reviewed periodically, and the effects of any changes are recognized at that time. Actual results could differ from the estimates used.
The global pandemic outbreak of the novel strain of coronavirus (“COVID-19”) has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, store closures, self-imposed quarantine periods and social distancing, may cause material disruption to businesses globally resulting in an economic slowdown. COVID-19, as well as the increase in inflation and gas prices, has cast uncertainty on the assumptions used by management in making its judgments and estimates. Management has not observed any indicators of impairment to assets or a significant change in the fair value of assets due to COVID-19. The Company implemented new safety procedures in accordance with the guidance from the CDC at all locations to better protect the health and safety of both employees and customers. The Company is re-assessing its response to and any potential impact of the COVID-19 pandemic on an ongoing basis.
The following areas require management’s critical estimates and judgments:
(a) | Business combinations |
A business combination is a transaction or event in which an acquirer obtains control of one or more businesses and is accounted for using the acquisition method. The total consideration paid for the acquisition is the aggregate of the fair values of assets acquired, liabilities assumed, and equity instruments issued in exchange for control of the acquiree at the acquisition date. The acquisition date is the date when the Company obtains control of the acquiree.
Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions.
Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates in accordance with the criteria and guidance provided under ASC 805 – Business Combinations.
Based on the facts and circumstances that existed at the acquisition date, management will perform a valuation analysis to allocate the consideration transferred based on the fair values of the identifiable assets acquired and liabilities assumed on the acquisition date. Management is required to finalize its allocation on the earlier of the date that information becomes known, but no later than one year from the acquisition date. Until such time, these values might be provisionally reported and are subject to change. During the measurement period, adjustments to provisional purchase price allocations are recognized if new information is obtained about the facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date.
In determining the fair value of all identifiable assets acquired and liabilities assumed, the most significant estimates generally relate to contingent consideration and intangible assets. Management exercises judgment in estimating the probability and timing of when contingent considerations are expected to be achieved, which is used as the basis for estimating fair value. Identified intangible assets are fair valued using appropriate valuation techniques which are generally based on a forecast of the total expected future net cash flows of the acquiree. Valuations are highly dependent on the inputs used and assumptions made by management regarding the future performance of these assets and any changes in the discount rate applied.
17
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.19 | Significant accounting judgments and estimates (continued) |
(a) | Business combinations (continued) |
Judgment is applied in determining whether a transaction is a business combination or an asset acquisition by considering the nature of the assets acquired and the processes applied to those assets, or if the integrated set of assets and activities is capable of being conducted and managed for the purpose of providing a return to investors or other owners.
(b) | Inventory |
In calculating the value of inventory, management is required to make a number of estimates, including estimating the stage of growth of the cannabis up to the point of harvest, expected yields for the cannabis plants, harvesting costs, net realizable value, selling costs, average or expected selling prices, fair value of inventory acquired in a business combination and impairment factors. In calculating final inventory values, management compares the inventory costs to estimated net realizable value as well as investigates slow moving inventory, if applicable. The estimates are judgmental in nature and are made at a point in time, using available information, such as expected business plans and expected market conditions. Periodic reviews are performed on the inventory balance with the changes in inventory reserves reflected in cost of goods sold.
(c) | Estimated useful lives and depreciation of PPE |
Depreciation of PPE is dependent upon estimates of useful lives, which are determined through the exercise of judgments. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.
(d) | Valuation, estimated life and impairment of intangible assets |
Management uses significant judgment in estimating the useful lives and impairment. Impairment tests rely on judgments and estimates related to growth rates, discount rates, and estimated margins.
(e) | Goodwill impairment |
Goodwill is tested for impairment annually on December 31st of each fiscal year and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, the Company may perform a qualitative assessment to determine if it was more-likely-than-not that the reporting unit’s carrying value is less than the fair value, indicating the potential for goodwill impairment. A number of factors, including historical results, business plans, forecasts, and market data are used to determine the fair value of the reporting unit. Changes in the conditions for these judgments and estimates can significantly affect the assessed value of goodwill. The Company has not recognized any goodwill impairments during the years ended December 31, 2021 and 2020.
(f) | Leases |
Each capitalized lease is evaluated to determine if the Company would exercise any of the renewal options offered. Several material factors are considered in determining if the renewal options would be exercised, such as length of the renewal, renewal rate, and ability to transfer locations. When measuring lease liabilities, the Company used discounted lease payments using a weighted-average rate in the range of
(g) | Provisions and contingent liabilities |
When the Company is more-likely-than-not to incur an outflow of resources to settle an obligation and the amount can be reasonably estimated, a contingent liability is recorded. The contingent liability is recorded at management’s best estimates of the expenditure required to settle the obligation at period end, discounted to the present value, if material.
18
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.19 Significant accounting judgments and estimates (continued)
(h) | Financial instruments |
To determine the fair value of financial instruments, the Company develops assumptions and selects certain methods to perform the fair value calculations. Various methods considered include but are not limited to: (a) assigning the value attributed to the transaction at the time of origination; (b) re-measuring the instrument if it requires concurrent fair value measurement; and (c) valuing the instrument at the issuance value less any amortized costs. As judgment is a factor in determining the value and selecting a method, as well as the inherent uncertainty in estimating the fair value, the valuation estimates may be different.
Application of the option pricing model requires estimates in expected dividend yields, expected volatility in the underlying assets, and the expected life of the financial instruments. These estimates may ultimately be different from amounts subsequently realized, resulting in an overstatement or understatement of net loss.
3.20 Change in accounting standards
The Company is treated as an “emerging growth company” per the definition under the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until the standards apply to private companies.
Recently Issued Accounting Standards
In June 2016, the FASB issued ASU 2016-13 Topic 326 Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which was subsequently revised by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11, ASU 2020-02 and ASU 2020-03 (“ASU 2016-13”), which introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. ASU 2016-13 is effective for the Company’s fiscal year beginning after December 15, 2021, and interim periods therein. The Company is evaluating the adoption date and impact, if any, adoption will have on its financial statements.
In December 2019, the FASB issued ASU 2019-12 Topic 740 – Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. ASU 2019-12 is effective for the Company’s fiscal year beginning after December 15, 2021, and interim periods therein. The Company is evaluating the adoption date and impact, if any, adoption will have on its financial statements.
In January 2020, the FASB issued ASU 2020-01 Topic 321 – Investments – Equity Securities, Topic 323 – Investments – Equity Method and Joint Ventures, and Topic 815 – Derivatives and Hedging (collectively “ASU 2020-01”), which is intended to clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for the Company’s fiscal year beginning after December 15, 2021, and interim periods therein. The Company is evaluating the adoption date and impact, if any, adoption will have on its financial statements.
In August 2020, the FASB issued ASU No. 2020-06 Subtopic 470-20 – Debt—Debt with Conversion and Other Options and Subtopic 815-40 Derivatives and Hedging—Contracts in Entity’s Own Equity: Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), to improve financial reporting associated with accounting for convertible instruments and contracts in an entity’s own equity. ASU 2020-06 is effective for the Company’s fiscal year beginning after December 15, 2021, including interim periods therein. The Company is evaluating the adoption date and impact, if any, adoption will have on its financial statements.
19
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
3.20 Change in accounting standards (continued)
In January 2017, the FASB issued ASU 2017-04 Topic 350 – Intangibles - Goodwill and Other, Simplifying the Accounting for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 removes the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. A goodwill impairment will now be the amount by which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. ASU 2017-04 is effective for the Company’s fiscal year beginning December 15, 2022. Early adoption is permitted for fiscal years beginning after January 1, 2017. The Company early adopted this guidance in 2021. There was no impact on the Company’s financial statements upon adoption.
In May 2021, the FASB issued ASU 2021-04 Topic 260 – Earnings Per Share, Subtopic 470-50 – Debt - Modifications and Extinguishments, Topic 718 – Compensation - Stock Compensation, Subtopic 815-40 – Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASU 2021-04”). ASU 2021-04 updates the guidance in connection with modifying equity issued warrants. The entity would recognize the increase in the warrant’s fair value as an equity issuance cost. The Company early adopted this guidance in 2021. There was no impact on the Company’s financial statements upon adoption.
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS
Each of the acquisitions are subject to specific terms relating to the satisfaction of the purchase price by the Company and its wholly-owned subsidiaries, and incorporates payments in cash, shares, and debt as well as certain contingent considerations. The shares issued as consideration are either Subordinate Shares or non-voting exchangeable shares of the Company’s subsidiaries (“Exchangeable Shares”) that are exchangeable on a
The goodwill recognized on acquisitions is attributable mainly to the expected future growth potential and expanded customer base arising as a result of the completion of the respective acquisition. Goodwill has been allocated to the reporting units corresponding to the states of the acquired businesses.
2021 Fourth Quarter Acquisition
Business combination
On October 4, 2021, the Company completed its acquisition of PA Natural through a membership interest purchase agreement.
Final valuations of the assets acquired and liabilities assumed are not yet complete due to the inherent complexity associated with valuations and the short period of time between the acquisition date and the period end. Therefore, the purchase price allocation is preliminary and subject to adjustment on completion of the valuation process and analysis of resulting tax effects. Further changes may still be required as management works to finalize the valuation of assets acquired and liabilities assumed. Differences between these provisional estimates and the final acquisition accounting may occur and these differences could have a material impact.
20
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
2021 Fourth Quarter Acquisition (continued)
Business combination (continued)
The preliminary fair value of the identifiable assets acquired and liabilities assumed as of the acquisition date are as follows:
| PA Natural | |
$ | ||
ASSETS ACQUIRED | ||
Cash | | |
Inventory, net | | |
Prepaid expenses and other assets | | |
Intangible assets-licenses/permits | | |
Property, plant, and equipment | | |
Right-of-use assets - operating | | |
Deposits | | |
Total assets acquired at fair value | | |
LIABILITIES ASSUMED | ||
Trade payables | | |
Accrued liabilities | | |
Lease liabilities - operating | | |
Total liabilities assumed at fair value | | |
Goodwill | | |
Consideration transferred | |
PA Natural Business Combination
PA Natural is an operator of three licensed retail dispensaries. PA Natural has locations in Bloomsburg, State College, and Selinsgrove, PA.
Purchase consideration was comprised of the following:
|
|
| Shares |
| Fair Value | ||
Cash |
| i |
|
| $ | | |
Debt Payable |
| ii |
|
| | ||
Shares Issued |
| iii |
| | | ||
Contingent Consideration |
| iv |
|
| | ||
Total |
|
|
| | $ | |
Pursuant to the terms of the Definitive Agreement (“PA Natural Agreement”), Ayr satisfied the purchase price of $
i. | $ |
ii. | $ |
21
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
PA Natural Business Combination (continued)
iii. | $ |
iv. | A portion of the PA Natural purchase price is derived from an earn-out provision through December 31, 2021 based on adjusted earnings before interest tax depreciation and amortization (“EBITDA”), a non-GAAP measure, consisting of cash, a promissory note, and Exchangeable Shares, valued through a Monte-Carlo simulation, that may entitle the sellers to earn additional consideration if certain milestones are achieved, see Note 13 for more information. |
2021 Third Quarter Acquisitions
Business combination
On September 15, 2021, the Company completed its acquisition of GSD NJ LLC (“Garden State Dispensary” or “GSD”) through a membership interest purchase agreement.
Asset Acquisition
On July 1, 2021, the Company completed its acquisitions of Eskar Holdings, LLC, (“Eskar”) through a membership interest purchase agreement. Collectively, the GSD and Eskar acquisitions are referred to as the “Q3 2021 Acquisitions”.
The details of the purchase consideration consist of cash, debt, Exchangeable Shares, and contingent consideration.
Final valuations of the assets acquired and liabilities assumed for the acquisition of GSD are not yet complete due to the inherent complexity associated with valuations and the short period of time between the acquisition date and the period end. Therefore, the purchase price allocation is preliminary and subject to adjustment on completion of the valuation process and analysis of resulting tax effects. During the year ended December 31, 2021, measurement period adjustments were recorded because of changes to various estimates and assumptions, with the cumulative effect impacting goodwill, such as intangible assets increasing $
22
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
2021 Third Quarter Acquisitions (continued)
Asset Acquisition (continued)
The preliminary fair value of the identifiable assets acquired and liabilities assumed for GSD as of the acquisition date are as follows:
| GSD |
| Eskar |
| Total | |
$ | $ | $ | ||||
ASSETS ACQUIRED | ||||||
Cash | |
| – |
| | |
Inventory, net | |
| – |
| | |
Prepaid expenses and other assets | |
| – |
| | |
Intangible assets - licenses/permits | |
| – |
| | |
Intangible assets - host community agreements | – |
| |
| | |
Property, plant, and equipment | |
| – |
| | |
Right-of-use assets - operating | |
| – |
| | |
Deposits | |
| – |
| | |
Total assets acquired at fair value | |
| |
| | |
LIABILITIES ASSUMED | ||||||
Trade payables | |
| – |
| | |
Accrued liabilities | |
| – |
| | |
Advance from related parties | |
| – |
| | |
Lease liabilities - operating | |
| – |
| | |
Debts payable | |
| – |
| | |
Total liabilities assumed at fair value | |
| – |
| | |
Goodwill | |
| – |
| | |
Consideration transferred | |
| |
| |
GSD Business Combination
GSD has three open dispensaries, the maximum allowed under its permit, at highway locations throughout the central region of the State of New Jersey, as well as approximately
Purchase consideration was comprised of the following:
|
| Shares |
| Fair Value | |||
Cash | i |
|
| $ | | ||
Debt Payable | ii |
|
|
| | ||
Shares Issued |
| iii |
| |
| | |
Contingent Consideration | iv | | |||||
Total |
|
|
| | $ | |
Pursuant to the terms of the Definitive Agreement (“GSD Agreement”), Ayr satisfied the purchase price of $
i. | $ |
23
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
GSD Business Combination (continued)
ii. | $ |
iii. | $ |
iv. | A portion of the GSD purchase price is derived from an earn-out provision through December 31, 2022, subject to extension, based on exceeding revenue target thresholds, consisting of cash, a promissory note, and Exchangeable Shares, valued through a Monte-Carlo simulation, that may entitle the sellers to earn additional consideration if certain milestones are achieved, see Note 13 for more information. |
Eskar Asset Acquisition
Pursuant to the agreements, the Company acquired rights to legally open and operate an adult-use cannabis licensed retail store along with the purchase of the property located in the Town of Watertown, Massachusetts.
The Eskar acquisition did not meet the definition of a business according to ASC 805 and as such, it was recorded as an asset acquisition.
Purchase consideration for the acquisition was $
2021 First Quarter Acquisitions
Business combinations
On February 26, 2021, the Company completed its acquisition of Liberty in a stock-for-stock combination. On March 23, 2021, the Company completed its acquisition of Oasis through a membership interest purchase agreement. On March 31, 2021, the Company completed its acquisition of Ohio Medical Solutions, LLC (“Ohio Medical”) through an asset purchase agreement.
Asset acquisition
On March 30, 2021, the Company completed its acquisition of Greenlight Management, LLC (“Greenlight Management”) and Greenlight Holdings, LLC (“Greenlight Holdings”) through a membership purchase agreement. Greenlight Management has a management agreement with Parma Wellness, Center, LLC (“Parma”). Collectively, the Liberty, Oasis, Ohio Medical, and Parma acquisitions are referred to as the “Q1 2021 Acquisitions”.
The details of the purchase consideration consist of cash, debt, Subordinate Shares, Exchangeable Shares, contingent consideration, purchase consideration payable, and replacement options issued.
24
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
2021 First Quarter Acquisitions (continued)
Asset acquisition (continued)
Final valuations of the assets acquired and liabilities assumed are not yet complete due to the inherent complexity associated with valuations and the short period of time between the acquisition date and the period end. Therefore, the purchase price allocation is preliminary and subject to adjustment on completion of the valuation process and analysis of resulting tax effects. During the year ended December 31, 2021, measurement period adjustments were recorded related to the Liberty transaction because of changes to various estimates and assumptions, with the cumulative effect impacting goodwill. Inventory decreased $
The fair value of the identifiable assets acquired and liabilities assumed as of the acquisition date are as follows:
| Liberty |
| Oasis |
| Parma |
| Ohio Medical |
| Total | |
| $ |
| $ |
| $ |
| $ |
| $ | |
ASSETS ACQUIRED | ||||||||||
Cash | | | – | – | | |||||
Accounts receivable | – | | – | | | |||||
Inventory, net | | | – | | | |||||
Prepaid expenses and other assets | | | – | | | |||||
Intangible assets - licenses/permits | | | – | | | |||||
Intangible assets - right-to-use licenses | – | – | | – | | |||||
Property, plant, and equipment | | | | | | |||||
Right-of-use assets - operating | | | – | | | |||||
Right-of-use assets - finance, net | | | – | – | | |||||
Deposits | | | – | | | |||||
Total assets acquired at fair value | | | | | | |||||
LIABILITIES ASSUMED | ||||||||||
Trade payables | | | – | – | | |||||
Accrued liabilities | | | – | | | |||||
Income tax payable | | – | – | – | | |||||
Deferred tax liabilities | | – | – | – | | |||||
Lease liabilities - operating | | | – | | | |||||
Lease liabilities - finance | | | – | – | | |||||
Debts payable | | – | – | – | | |||||
Accrued interest | | – | – | – | | |||||
Total liabilities assumed at fair value | | | – | | | |||||
Goodwill | | | – | – | | |||||
Consideration transferred | | | | | |
25
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
Liberty Business Combination
Liberty is a vertically integrated cannabis company with cultivation, processor, transporter, and retail dispensary operations in Florida. Liberty owns a
Purchase consideration was comprised of the following:
|
|
| Shares |
| Fair Value | ||
Share Capital |
| i |
| | $ | | |
Purchase Consideration Payable |
| ii |
| | | ||
Replacement Options Issued |
| iii |
| | | ||
Total |
|
|
| | $ | |
Pursuant to the terms of the Definitive Agreement (“Liberty Agreement”), Ayr satisfied the purchase price of $
i. | $ |
ii. | $ |
iii. | $ |
Oasis Business Combination
Oasis is a vertically integrated cannabis company with a cultivation, processing, and retail dispensary operations in Arizona. Oasis operates a
Purchase consideration was comprised of the following:
|
|
| Shares |
| Fair Value | ||
Cash |
| i |
|
| $ | | |
Debt Payable |
| ii |
|
|
| | |
Shares Issued |
| iii |
| |
| | |
Contingent Consideration |
| iv |
|
|
| | |
Total |
|
|
| | $ | |
26
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Continued)
Oasis Business Combination (continued)
Pursuant to the terms of the Definitive Agreement (“Oasis Agreement”), Ayr satisfied the purchase price of $
i. | $ |
ii. | $ |
iii. | $ |
iv. | A portion of the Oasis purchase price is derived from an earn-out provision through December 31, 2022 based on adjusted EBITDA, a non-GAAP measure, consisting of cash and Exchangeable Shares, valued through a Monte-Carlo simulation, that may entitle the sellers to earn additional consideration if certain milestones are achieved, see Note 13 for more information. |
Parma Asset Acquisition
Greenlight Management operates on a
As the Parma acquisition did not meet the definition of a business according to ASC 805, and as such, it was recorded as an asset acquisition. Purchase consideration for the acquisition was $
Ohio Medical Business Combination
Ohio Medical is a cannabis processor and manufacturer in the Ohio medical market with a
Purchase consideration for the combination was $
2020 Fourth Quarter Acquisitions
On November 18, 2020, CSAC AcquisitionCo completed its acquisition of DocHouse, LLC (“DocHouse”) through a membership interest purchase agreement. On December 23, 2020, CSAC PA, a wholly-owned subsidiary in Nevada, United States, completed its acquisition of CannTech PA through a membership interest purchase agreement. Collectively, the DocHouse and CannTech PA acquisitions are referred to as the “Q4 2020 Acquisitions”.
The details of the purchase price consideration consist of cash, debt, Subordinate Shares, and Exchangeable Shares.
27
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATION AND ASSET ACQUISITIONS (Continued)
Ohio Medical Business Combination (continued)
2020 Fourth Quarter Acquisitions (continued)
The fair value of the identifiable assets acquired and liabilities assumed as of the acquisition date are as follows:
DocHouse | CannTech PA | Total | ||||
| $ |
| $ |
| $ | |
ASSETS ACQUIRED | ||||||
Cash | – |
| |
| | |
Inventory, net | – |
| |
| | |
Prepaid expenses, deposits, and other current assets | – |
| |
| | |
Intangible assets - licenses/permits | |
| |
| | |
Property, plant, and equipment | |
| |
| | |
Right-of-use assets - operating | – |
| |
| | |
Deposits and other assets | – |
| |
| | |
Total assets acquired at fair value | |
| |
| | |
LIABILITIES ASSUMED | ||||||
Trade payables | |
| |
| | |
Accrued liabilities | |
| |
| | |
Advance from related parties | |
| |
| | |
Lease liabilities - operating | – |
| |
| | |
Debts payable | – |
| |
| | |
Total liabilities assumed at fair value | |
| |
| | |
Goodwill | – |
| |
| | |
Consideration transferred | |
| |
| |
DocHouse Asset Acquisition
DocHouse owns real property with a grower/processor permit in the Pennsylvania medical cannabis market.
As DocHouse did not meet the definition of a business according to ASC 805, it was recorded as an asset acquisition. Purchase consideration was comprised of the following:
|
|
| Shares |
| Fair Value | ||
Cash |
| i |
|
| $ | | |
Debt Payable |
| ii |
|
|
| | |
Shares Issued |
| iii |
| |
| | |
Total |
|
|
| | $ | |
28
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATION AND ASSET ACQUISITIONS (Continued)
DocHouse Asset Acquisition (continued)
Pursuant to the terms of the Definitive Agreement (“DocHouse Agreement”), Ayr satisfied the purchase price of $
i. | $ |
ii. | $ |
iii. | $ |
CannTech PA Business Combination
CannTech PA is a vertically integrated cannabis company with a grower/processor and dispensary permit in the Pennsylvania medical market. CannTech PA has a permit to operate six retail dispensaries and a cultivation and processing facility.
The purchase consideration was comprised of the following:
|
| Shares |
| Fair Value | |||
Cash |
| i |
|
| $ | | |
Debt Payable |
| ii |
|
|
| | |
Shares Issued |
| iii |
| |
| | |
Total |
|
|
| | $ | |
Pursuant to the terms of the Definitive Agreement (“CannTech PA Agreement”), Ayr satisfied the purchase price of $
i. | $ |
ii. | $ |
iii. | $ |
Fair Value Considerations
The consideration has been allocated to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. Transactions accounted for as business combinations have been accounted for in accordance with ASC 805, with the results included in the Company’s net loss from the date of acquisition.
29
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
4. BUSINESS COMBINATION AND ASSET ACQUISITIONS (Continued)
Fair Value Considerations (continued)
The earn-out consideration is measured at fair value based on unobservable inputs and is considered a Level 3 measurement. The fair value was determined by the Company’s share price at the acquisition date and other inputs based on other observable market data. The earn-out provisions in the Oasis, GSD, and PA Natural Agreements have been measured at fair value by using a Monte-Carlo simulation model. Refer to Note 13 for the contingent consideration fair value treatment subsequent to the acquisition.
Supplemental Pro-Forma Information
Revenue and income before taxes attributable to Liberty, Oasis, GSD, and PA Natural for the year ended December 31, 2021, were $
5. INVENTORY
The Company’s inventory includes the following:
| December 31, |
| December 31, | |||
2021 | 2020 | |||||
Materials, supplies, and packaging | $ | | $ | | ||
Work in process | | | ||||
Finished goods |
| |
| | ||
Incremental costs to acquire cannabis inventory in a business combination, net | | – | ||||
Total inventory, net | $ | | $ | |
Inventory reserve as of December 31, 2021 and 2020 was $
Amount of inventory included in cost of goods sold during the years ended December 31, 2021 and 2020, was $
For the years ended December 31, 2021 and 2020, $
30
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
6. PROPERTY, PLANT, AND EQUIPMENT
|
|
|
| Buildings, |
| ||||||||||||||||
Machinery | leasehold | ||||||||||||||||||||
Furniture and | Office | and | Auto and | improvements, | Construction in | ||||||||||||||||
| fixtures |
| equipment |
| equipment |
| trucks |
| and land |
| Progress |
| Total | ||||||||
Cost | |||||||||||||||||||||
As of January 1, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2021 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | | ||||||
Accumulated Depreciation |
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
As of January 1, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | – | $ | | ||||||
As of December 31, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | – | $ | | ||||||
As of December 31, 2021 | $ | | $ | |
| $ | | $ | | $ | | $ | – | $ | | ||||||
Net book value |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
As of January 1, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2020 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2021 | $ | | $ | |
| $ | | $ | | $ | | $ | | $ | |
During the years ended December 31, 2021 and 2020, the Company capitalized borrowing costs of $
Depreciation and amortization expense relating to PPE for the years ended December 31, 2021 and 2020:
Year Ended | ||||
December 31, | December 31, | |||
2021 | 2020 | |||
| $ |
| $ | |
Cost of goods sold | |
| | |
Expenses | |
| | |
Total depreciation relating to PPE | |
| |
31
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
7. GOODWILL AND INTANGIBLE ASSETS
Goodwill
There were no indicators of impairment during the years presented. As of December 31, 2021 and 2020, the Company’s goodwill is as follows:
| Total | ||
As of January 1, 2020 | $ | | |
Acquired through business combinations |
| | |
As of December 31, 2020 | $ | | |
Acquired through business combinations |
| | |
As of December 31, 2021 | $ | |
Intangible Assets
Amortization expense is recorded within cost of goods sold and total expenses. The amount in cost of goods sold for the years ended December 31, 2021 and 2020, was $
|
| Right-to-use | Host community |
| Trade name / |
|
|
| ||||||||
Licenses/Permits | licenses | agreements | brand |
| ||||||||||||
Useful life (# of years) |
| 15 |
| 15 |
| 15 |
| 5 |
| Total |
| |||||
Cost |
|
|
|
|
|
| ||||||||||
As of January 1, 2020 |
| $ | |
| $ | |
| $ | | $ | | $ | |
| ||
As of December 31, 2020 | $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2021 | $ | |
| $ | |
| $ | | $ | | $ | |
| |||
Accumulated Amortization |
|
|
|
|
|
|
|
| ||||||||
As of January 1, 2020 | $ | |
| $ | |
| $ | | $ | | $ | |
| |||
Amortization |
| |
|
| |
|
| |
| |
| |
| |||
As of December 31, 2020 | $ | | $ | | $ | | $ | | $ | | ||||||
Amortization | | | | | | |||||||||||
As of December 31, 2021 | $ | |
| $ | |
| $ | | $ | | $ | |
| |||
Net book value |
|
|
|
|
|
|
|
| ||||||||
As of January 1, 2020 | $ | | $ | | $ | | $ | | $ | | ||||||
As of December 31, 2020 | $ | |
| $ | |
| $ | | $ | | $ | |
| |||
As of December 31, 2021 | $ | |
| $ | |
| $ | | $ | | $ | |
|
The anticipated amortization expense over the next five years is as follows:
Amortization |
| 2022 |
| 2023 |
| 2024 |
| 2025 |
| 2026 |
| 2027 and beyond | |||||||
Expense | $ | | $ | | $ | | $ | | $ | | $ | |
32
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
8. RIGHT-OF-USE ASSETS & LEASE LIABILITIES
Information related to operating and finance leases is as follows:
December 31, 2021 | December 31, 2020 |
| |||||||
| Operating Leases |
| Finance Leases |
| Operating Leases |
| Finance Leases |
| |
Weighted average discount rate |
| | % | | % | | % | | % |
Weighted average remaining lease term |
|
|
|
|
The maturity of the contractual undiscounted lease liabilities as of December 31, 2021, are as follows:
| Operating Leases |
| Finance Leases |
| Total | ||||
2022 |
| $ | | $ | | $ | | ||
2023 |
| | | | |||||
2024 |
| | | | |||||
2025 |
| | | | |||||
2026 |
| | | | |||||
2027 and beyond | | — | | ||||||
Total undiscounted lease liabilities |
| $ | | $ | | $ | | ||
Impact of discounting | ( | ( | ( | ||||||
Total present value of minimum lease payments | $ | | $ | | $ | |
Payments related to capitalized leases during the years ended December 31, 2021 and 2020, are as follows:
Year Ended | ||||||
| December 31, 2021 |
| December 31, 2020 | |||
Lease liabilities - operating | ||||||
Lease liabilities - operating expense, COGS | $ | | $ | | ||
Lease liabilities - operating expense, G&A |
| |
| | ||
Lease liabilities - finance |
|
|
|
| ||
Amortization of right-of-use assets, COGS |
| |
| | ||
Amortization of right-of-use assets, G&A |
| |
| — | ||
Interest on lease liabilities - finance, COGS |
| |
| | ||
Interest on lease liabilities - finance, G&A |
| |
| — | ||
Total lease expense | $ | | $ | |
33
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
9. EQUITY INVESTMENTS
The Company has a
| December 31, 2021 |
| December 31, 2020 | |||
Balance, at the beginning of the period | $ | | $ | | ||
Investment |
| |
| | ||
Share of loss |
| ( |
| ( | ||
Disposal | ( | – | ||||
Carrying amount | $ | – | $ | |
The following table presents a summary of the balance sheets and statements of operations of Green Garden:
| December 31, 2021 |
| December 31, 2020 | |||
Current assets | $ | – | $ | | ||
Non-current assets |
| – |
| – | ||
Current liabilities |
| – |
| – | ||
Revenue |
| – |
| – | ||
Loss |
| – |
| ( |
During the year ended December 31, 2021, Ayr received $
10. RELATED PARTY TRANSACTIONS AND BALANCES
Related parties are defined as management and members of the Company and/or members of their immediate family and/or other companies and/or entities in which a board member or senior officer is a principal owner or senior executive. Other than disclosed elsewhere in the financial statements, related party transactions and balances are as follows:
Mercer Park, L.P., a company owned by an executive of Ayr, entered into a management agreement with the Company dated May 24, 2019. As of December 31, 2021, and 2020, $
The management fee is paid monthly and varies based on actual costs incurred by the related entity when providing the Company administrative support, management services, office space, and utilities. In addition, the management fees pay other corporate or centralized expenses based on actual cost, including but not limited to legal and professional fees, software, and insurance. The agreement is a month-to-month arrangement.
As of December 31, 2021, and 2020, Glass House Brands Inc. (“Glass House”), formerly, Mercer Park Brand Acquisition Corp., a company that had limited services shared with the Company, owed to Ayr $
During the year ended December 31, 2021, the Company incurred fees from Panther Residential Management, LLC (“Panther”), a company partially owned by a board member of Ayr. The total incurred fees were $
34
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
Refer to Notes 11 and 14 for additional information around the debts payable and non-cash stock-based compensation plan and calculation, respectively, for the years ended December 31, 2021 and 2020.
35
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
11. DEBTS PAYABLE & SENIOR SECURED NOTES
Senior Secured Notes
On December 10, 2020, the Company completed an offering to a syndicate of institutional investors comprising four-year senior secured promissory notes (the “December 2020 Notes”) with a face value of $
On November 12, 2021, the Company completed a private placement offering of approximately $
| Senior secured notes | ||
As of January 1, 2020 | $ | — | |
Debt issued | | ||
Debt issuance costs | ( | ||
Debt issuance costs amortized | | ||
As of December 31, 2020 | | ||
Debt issuance costs | ( | ||
Debt issuance costs amortized | | ||
Senior Secured Notes issued | | ||
Senior Secured Notes premium | | ||
Senior Secured Notes premium amortized | ( | ||
Total senior secured notes payable as of December 31, 2021 | $ | | |
Total accrued interest payable related to senior secured notes as of December 31, 2021 | $ | |
36
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
11. DEBTS PAYABLE & SENIOR SECURED NOTES (Continued)
Debt payable
| Debts Payable | ||
As of January 1, 2020 | $ | | |
Acquired through combinations and acquisitions | | ||
Less: repayment | ( | ||
Less: discounted to fair value | ( | ||
As of December 31, 2020 | | ||
Discounted as of December 31, 2020 |
| | |
Acquired through combinations and acquisitions |
| | |
Converted to equity |
| ( | |
Less: repayment |
| ( | |
Total debts payable, undiscounted as of December 31, 2021 |
| | |
Less: discounted to fair value | ( | ||
Total debts payable as of December 31, 2021 | $ | | |
Total accrued interest payable related to debts payable as of December 31, 2021 | $ | |
The details of debts payable were as follows:
December 31, 2021 | |||||||||
| Related party debt |
| Non-related party debt |
| Total debt | ||||
Principal payments |
| $ | |
| $ | |
| $ | |
Less: current portion | |
| |
| | ||||
Total non-current debt, undiscounted | $ | | $ | | $ | | |||
Less: discount to fair value |
| – |
| ( |
| ( | |||
Total non-current debt | $ | | $ | | $ | |
The following table presents the future debt obligation as of December 31, 2021:
Future debt obligations (per year) |
|
| |
2022 | $ | | |
2023 |
| | |
2024 |
| | |
2025 |
| | |
Total debt obligations | $ | |
As part of the business combinations and asset acquisitions, the Company issued and assumed notes with related and non-related parties. The related party notes are considered part of the purchase price to the former shareholders of the acquired businesses. As a result of the combinations and acquisitions, several of these individual shareholders are now considered related parties of the Company across various roles including directors, officers, and shareholders.
Pursuant to the agreement to acquire Sira, the Company issued a related-party promissory note in the amount of $
Pursuant to the agreement to acquire Canopy, the Company issued a related-party promissory note in the amount of $
37
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
11. DEBTS PAYABLE & SENIOR SECURED NOTES (Continued)
Debt Payable (continued)
Pursuant to the agreement to acquire Washoe, the Company issued a related-party promissory note in the amount of $
Pursuant to the agreement to acquire LivFree, the Company issued a related-party promissory note in the amount of $
Pursuant to the agreement to acquire CannaPunch, the Company issued a related-party promissory note in the amount of $
Pursuant to the DocHouse Agreement, the Company issued non-related party promissory notes in the amount of $
Pursuant to the CannTech PA Agreement, the Company issued non-related party promissory notes in the amount of $
Pursuant to the Oasis Agreement, the Company issued non-related party promissory notes in the amount of $
Pursuant to the GSD Agreement, the Company issued non-related party promissory notes in the amount of $
Pursuant to the PA Natural Agreement, the Company issued non-related party promissory notes in the amount of $
Interest expense associated with related party debt payable for the years ended December 31, 2021 and 2020, was $
Convertible Debt
Pursuant to the Liberty Agreement, the Company agreed to assume non-related party convertible debt with a face value of $
38
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
12. SHARE CAPITAL
The authorized share capital of the Company is comprised of the following:
Unlimited number of Subordinate Shares
● |
● | Trading on the CSE under the symbol “AYR.A” and the OTC under the symbol “AYRWF”. |
Unlimited Number of Multiple Voting Shares
● |
● | Convertible into Subordinate Shares on a |
● | Not traded on the CSE. |
A summary of the outstanding share capital of the Company as of December 31, 2021, is comprised of the activity below. For additional shares reserved for issuance refer to Note 14 for stock-based compensation.
Initial Public Offering
On December 21, 2017, the Company completed its Offering and issued the following:
● |
● |
Qualifying Transaction
On May 24, 2019, the Company completed its Qualifying Transaction. As a result,
● |
● |
● |
Post Qualifying Transaction
The following activity occurred subsequent to the Qualifying Transaction:
● |
39
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
12. SHARE CAPITAL (Continued)
Post Qualifying Transaction (continued)
1. |
2. |
3. |
● |
● |
● |
o | On October 1, 2019, the Company commenced a stock repurchase program where |
o | On August 25, 2021, the Company commenced a stock repurchase program where |
● |
● | On January 14, 2021, the Company closed its equity offering of |
● | In relation to the exercise of |
● |
Post Qualifying Transaction Combinations and Acquisitions
The following activity occurred subsequent to the Qualifying Transaction that relate to business combinations and asset acquisitions:
● | As part of the Q4 2020 Acquisitions, the Company issued: |
o |
o |
40
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
12. SHARE CAPITAL (Continued)
Post Qualifying Transaction Combinations and Acquisitions (continued)
● | As part of the Q1 2021 Acquisitions, the Company issued: |
o |
o |
● | As part of the Q3 2021 Acquisition, the Company issued: |
o |
● | As part of the Q4 2021 Acquisition, the Company issued: |
o |
On November 4, 2020, the Company created two new share classes, Restricted Voting Shares and Limited Voting Shares, including applying terms to such shares similar to those applicable to the existing Subordinate Voting Shares (except that Limited Voting Shares have no rights to vote for directors), and amended the terms of the existing Multiple Voting Shares and existing Subordinate Voting Shares by amending the requirements on who may hold Subordinate Voting Shares, which is limited to non-US persons. The amendment in share structure was designed to seek to ensure Ayr’s status as a Foreign Private Issuer.
Warrants
Warrants issued and outstanding are each exercisable on a
For the 2019 Early Exercise Period and 2020 Incentive Program issuances, the Company made an incentive payment of $
41
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
12. SHARE CAPITAL (Continued)
Warrants (continued)
The average remaining life of Warrants is
| Number |
| Amount | ||
Balance as of December 31, 2019 |
| | $ | | |
Exercise of Warrants |
| ( |
| ( | |
Balance as of December 31, 2020 |
| | $ | | |
Balance as of December 31, 2020 |
| | $ | | |
Exercise of Warrants |
| ( | ( | ||
Forfeitures of Warrants, due to expiration |
| ( |
| ( | |
Balance as of December 31, 2021 |
| | $ | |
13. DERIVATIVE LIABILITIES
Purchase Consideration and Contingent Consideration
As part of the purchase price of the Qualifying Transaction, the Company entered into make-whole provisions relating to the Exchangeable Shares issued. The Company uses a Monte-Carlo simulation model to estimate the fair value of the make-whole provision liability. Upon initial recognition, the Company recorded a derivative liability of $
The earn-out provision related to the acquisition of Sira is measured at fair value by taking a probability-weighted average of possible outcomes, as estimated by management, and discounting the payment to a present value. Upon initial recognition, the fair value of the contingent consideration liability was recorded as $
The earn-out provisions related to the acquisitions of Oasis, GSD, and PA Natural are measured at fair value using a Monte-Carlo simulation to estimate the fair value through the end of the earn-out period. Upon initial recognition, the fair value of the contingent consideration liabilities were recorded as $
As of December 31, 2021, the fair value of Oasis’s earn-out provision was $
The fair value adjustment relating to derivative liabilities has been reflected in the financial statements under “Fair value gain (loss) on financial liabilities” as detailed below:
| Year Ended | |||||
December 31, | December 31, | |||||
| 2021 |
| 2020 | |||
(Loss) from FV adjustment on make-whole provision | $ | – | $ | ( | ||
Gain (loss) from FV adjustment on contingent consideration |
| |
| ( | ||
Gain from FV adjustment on purchase consideration settlement | | – | ||||
Total | $ | | $ | ( |
42
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
14. STOCK-BASED COMPENSATION
The Company has adopted an Equity Incentive Plan (“the Plan”), as amended on May 2, 2021, which allows the Company to compensate qualifying plan participants through stock-based arrangements and provide them with opportunities for stock ownership in the Company, thereby aligning the interests of such persons with the Company’s shareholders. Under the Plan, the Company may grant stock options, RSUs, performance compensation awards, and unrestricted stock bonuses or purchases.
In addition, CSAC AcquisitionCo established a Restricted Stock Plan (the “AcquisitionCo Plan”) to facilitate the granting of restricted Exchangeable Shares. Any shares issued under the AcquisitionCo Plan will reduce the number of Subordinate Shares that may be awarded under the Equity Incentive Plan on a
basis.The stock-based compensation expense is based on either the Company’s share price for service-based conditions or the Company's share price fair value on the date of the grant. The RSUs vest over a
During the years ended December 31, 2021, and 2020,
Weighted | |||||
Average Grant | |||||
| Number |
| Date Fair Value | ||
RSUs outstanding and nonvested, as of January 1, 2020 |
| |
| $ | |
Granted |
| | $ | | |
RSUs outstanding and nonvested, as of December 31, 2020 |
| | $ | | |
Granted | | | |||
Vested | ( | ( | |||
RSUs outstanding and nonvested, as of December 31, 2021 | | $ | |
Options
As part of the Liberty acquisition, the Company issued replacement options to certain employees of Liberty who became employees of the Company and recorded additional paid-in capital of $
| Weighted Average | ||||
Number of options |
| Fair Value | |||
Balance as of December 31, 2020 | – | $ | – | ||
Replacement options issued | | | |||
Options exercised | ( | | |||
Options sold to cover income taxes | ( | | |||
Balance as of December 31, 2021 | | |
43
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
15. COMMITMENTS AND CONTINGENCIES
Contingencies
The Company’s operations are subject to a variety of local and state governmental regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits and/or licenses that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance, in all material respects, with applicable local and state governmental regulations as of December 31, 2021, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.
Claims and Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. As of December 31, 2021, there were no material pending or threatened lawsuits that could be reasonably expected to have a material effect on the results of the Company’s operations. There are also no proceedings in which any of the Company's directors, officers or affiliates are an adverse party or have a material interest adverse to the Company's interest.
Construction Commitments
As of December 31, 2021, the Company had $
Acquisitions – Definitive Agreement and Term Sheet
Nevada
On July 19, 2021, the Company entered a definitive purchase agreement to acquire Tahoe Hydroponics Company, LLC (Tahoe Hydro”), a cultivation and production company, and NV Green, Inc (“NV Green”) a production company. Ayr intends to purchase
Massachusetts
On September 7, 2021, the Company entered a definitive agreement to acquire Cultivauna, LLC (“Cultivauna”), the owner of Levia branded cannabis infused beverages and tinctures. Ayr intends to purchase
Illinois
On July 20, 2021, the Company entered into a definitive agreement to acquire Herbal Remedies Dispensaries, LLC (“Herbal”), an operator of
On August 9, 2021, Lincoln was awarded a conditional retail dispensary license in Illinois via the state’s lottery process.
On November 22, 2021, the Company has entered into a definitive agreement to acquire Gentle Ventures, LLC and certain of its affiliates d/b/a Dispensary 33 (“Dispensary 33”) that collectively own and operate
44
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
16. FINANCIAL RISK FACTORS
(a) Fair value
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability or, in the absence of a principal market, in the most advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Company.
The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits from the asset’s highest and best use or by selling it to another market participant that would utilize the asset in its highest and best use.
The Company uses valuation techniques that are considered to be appropriate in the circumstances and for which there is sufficient data with unobservable inputs.
All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy. This is described, as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
● | Level 1 inputs are quoted prices in active markets for identical assets or liabilities at the measurement date. |
● | Level 2 inputs are observable inputs other than quoted prices included within Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable directly or indirectly. |
● | Level 3 inputs are unobservable inputs for the asset or liability that reflect the reporting entity’s own assumptions and are not based on observable market data. |
There
The carrying values of cash, deposits, accounts receivables, trade payables, accrued liabilities, accrued interest payable, and purchase consideration payable approximate their fair values because of the short-term nature of these financial instruments. Long-term debt is recorded at amortized cost.
The following table summarizes the fair value hierarchy for the Company’s financial assets and liabilities that are re-measured at their fair values periodically:
December 31, 2021 |
| Level 1 |
| Level 2 |
| Level 3 |
| Total | ||||
Financial Liabilities |
|
|
|
|
|
|
|
| ||||
Contingent consideration |
| $ | – |
| $ | – |
| $ | |
| $ | |
December 31, 2020 |
|
|
|
|
|
| ||||||
Financial Liabilities |
|
|
|
|
|
| ||||||
Contingent consideration |
| $ | – |
| $ | – |
| $ | |
| $ | |
45
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
16. FINANCIAL RISK FACTORS (Continued)
(a) Fair value (continued)
The following table summarizes the inputs used to value the contingent consideration in the table above:
Equity Volatility |
| % | |
Revenue Volatility |
| | % |
Risk-free rate |
| % | |
Revenue RMRP |
| | % |
Credit Risky Rate |
| | % |
Discount Rate |
| | % |
The Company is exposed to credit risk, liquidity risk, and interest rate risk. The Company’s management oversees the management of these risks. The Company’s management is supported by the members of the Board of Directors that advise on financial risks and the appropriate financial risk governance framework for the Company. The Company’s financial risk activities are governed by policies and procedures and financial risks are identified, measured, and managed in accordance with the Company’s policies and the Company’s risk appetite.
(b) Credit risk
Credit risk is the risk of unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash, deposits, and accounts receivable. To address its credit risk arising from cash and deposits, the Company ensures to keep these balances with reputable financial institutions. As of December 31, 2021, and 2020, substantially all of cash is estimated to be exposed to credit risks. The components of accounts receivable as of December 31, 2021, and 2020, were:
| 0-30 days |
| 31-90 days |
| Over 90 days |
| Total | |||||
Balance, as of December 31, 2021 | $ | | $ | | $ | | $ | | ||||
Balance, as of December 31, 2020 |
| |
| |
| – |
| |
(c) Liquidity risk
Liquidity risk is the risk that the Company is unable to generate or obtain sufficient cash in a cost-effective manner to fund its obligations as they come due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. The Company manages liquidity risk through maintaining sufficient funds on hand and continuously monitoring forecast and actual cash flows. Refer to Notes 8 and 11 for future lease and debt commitments. The Company has the following gross obligations as of December 31, 2021, which are expected to be payable:
| Less than 1 year |
| 1-5 years |
| > 5 years |
| Total | |||||
Trade payables and accrued liabilities |
| $ | | $ | – | $ | – | $ | | |||
Lease obligations |
| |
| |
| |
| | ||||
Purchase consideration |
| |
| – |
| – |
| | ||||
Income tax payable |
| |
| – |
| – |
| | ||||
Debt Payable |
| |
| |
| – |
| | ||||
Contingent consideration |
| |
| |
| – |
| | ||||
Senior secured notes |
| – |
| |
| – |
| | ||||
Accrued interest payable |
| |
| |
| – |
| | ||||
$ | | $ | | $ | |
| |
46
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
16. FINANCIAL RISK FACTORS (Continued)
(d) Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash and long-term debts. Cash and deposits bear interest at market rates. The Company’s debts have fixed rates of interest. The Company does not use any derivative instruments to hedge against interest rate risk and believes that the change in interest rates will not have a significant impact on its financial results.
(e) Currency risk
The operating results and financial position of the Company are reported in United States dollars. As the Company operates in an international environment, some of the Company’s financial instruments and transactions are denominated in currencies other than the United States dollar. The results of the Company’s operations are subject to currency transaction and translation risks.
As of December 31, 2021 and 2020, the Company had
Value at year end | Effect on fair value, as at | |||||||
| Dr (Cr.) |
|
|
| December 31, 2021 | |||
Balance sheet account | CDN $ | Conversion rate | Sensitivity | $ | ||||
Cash |
| |
| |
| Increase / Decrease | % | |
17. TAXATION
The Company is a Canadian corporation and is classified as a U.S. domestic corporation for U.S. federal income tax purposes under the Section 7874(b) “inversion” rules of the U.S. Tax Code therefore is subject to taxation both in Canada and the United States. The Company maintains all of its operations in the United States. As the Company operates in the cannabis industry, it is subject to the limitations of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss.
The domestic and foreign components of loss before income taxes for the years ended December 31, 2021 and 2020 are as follows:
Year Ended | ||||||
| 2021 |
| 2020 | |||
Domestic | $ | | $ | | ||
Foreign |
| ( |
| ( | ||
Income (loss) before income taxes |
| |
| ( |
47
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
17. TAXATION (Continued)
For the years ended December 31, 2021 and 2020 income taxes expense consisted of:
Year Ended | ||||||
| 2021 |
| 2020 | |||
Current taxes: |
|
|
|
| ||
Federal | $ | | $ | | ||
State |
| |
| | ||
Total Current | | | ||||
Deferred taxes: |
|
| ||||
Federal | ( | | ||||
State |
| ( |
| | ||
Foreign | ( | ( | ||||
Change in valuation allowance | | | ||||
Total Deferred | ( | | ||||
Total income tax expense: | $ | | $ | |
The difference between the income tax expense for the years ended December 31, 2021 and 2020 and the expected income taxes based on the statutory tax rate applied to income (loss) before income tax as follows:
| Years Ended |
| |||||
2021 |
| 2020 | |||||
Income (Loss) before income taxes |
| $ | | $ | ( | ||
Statutory tax rates |
| | % |
| | % | |
Expense (Recovery) based on statutory rates |
| | ( | ||||
Foreign tax rate differential |
| ( | ( | ||||
State taxes |
| | | ||||
Acquisitions costs |
| | | ||||
Non-deductible expenses |
| | | ||||
Tax rate change |
| ( | | ||||
Change in valuation allowance | | | |||||
Other differences | | ( | |||||
Income tax expense | $ | | $ | |
48
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
17. TAXATION (Continued)
At December 31, 2021 and 2020, the components of deferred tax assets and liabilities were as follows:
| Year Ended December 31, | |||||
| 2021 |
| 2020 | |||
Deferred tax assets | ||||||
Net operating losses | $ | | $ | | ||
Share issuance costs | | | ||||
Investments | | | ||||
Inventory | | | ||||
Other assets | | | ||||
Total deferred tax assets | | | ||||
Valuation allowance | ( | ( | ||||
Total deferred tax assets | | | ||||
Deferred tax liabilities | ||||||
Depreciation | $ | ( | $ | ( | ||
Amortization | ( | ( | ||||
Debt financing costs | ( | ( | ||||
Other liabilities | ( | ( | ||||
Total deferred tax liabilities | ( | ( | ||||
Net deferred tax liabilities | $ | ( | $ | ( |
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company assesses the positive and negative evidence to determine if sufficient future taxable income is expected to be generated to use the existing deferred tax assets. On the basis of our assessment, the valuation allowance increased $
As of December 31, 2021 and 2020, Ayr had $
The Company operates in a number of United States state tax jurisdictions and is subject to examination of its income tax returns by tax authorities in those jurisdictions who may challenge any item on these returns. Because the tax matters challenged by tax authorities are typically complex, the ultimate outcome of these challenges is uncertain. In accordance with ASC 740—Income Taxes, the Company recognizes the benefits of uncertain tax positions in our financial statements only after determining that it is more likely than not that the uncertain tax positions will be sustained.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. There are no positions for which it is reasonably possible that the uncertain tax benefit will significantly increase or decrease within twelve months. Ayr files income tax returns in the United States, various state jurisdictions, and Canada, which remain open to examination by the respective jurisdictions for the 2018 tax year to the present.
49
Ayr Wellness Inc. (formerly Ayr Strategies Inc.)
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2021 and 2020
18. SUBSEQUENT EVENTS
The Company’s management has evaluated subsequent events through the date the financial statements were issued.
Subsequent to December 31, 2021, the Company entered into an interim management services agreement with Tahoe Hydro and NV Green whereby Ayr is providing services under a management agreement.
Subsequent to December 31, 2021, the Company completed its definitive agreement with Cultivauna. Supplemental pro-forma information required by ASC 805 is not practicable.
Subsequent to December 31, 2021, pursuant to the PA Natural Agreement, the Company paid out the earn-out provision from the PA Natural purchase price. The amount consisted of $
Subsequent to December 31, 2021, the Company entered into a loan agreement with a community bank for total proceeds of $
50